Every S-3 that Health In Tech, Inc. (HIT) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A S-3 covers the shelf registration that lets an established company sell over time, so if you follow HIT and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full HIT filings page.
Health In Tech, Inc. (HIT) filed a shelf registration to permit YA II PN, LTD (Yorkville) to resell up to 29,532,889 shares of its Class A common stock that may be issued under a Standby Equity Purchase Agreement (SEPA) and related Convertible Notes. The registration covers 9,532,889 Conversion Shares issuable upon note conversions and 20,000,000 Advance Shares issuable through equity advances. Health In Tech will not receive proceeds from Yorkville’s resale of these shares, but may receive up to $14.25 million from Convertible Notes and up to $20.0 million from share sales to Yorkville under the SEPA, with initial proceeds used to repay the notes. As of September 2, 2026, shares outstanding were 53,702,649, and Nasdaq rules impose a 13,100,378‑share Exchange Cap and a 4.99% Beneficial Ownership Limitation, so additional issuances would require stockholder approval. The company describes significant potential dilution to existing holders and expects longer‑term SEPA proceeds, once available beyond note repayment, to support sales expansion, technology and product development, and working capital.
Health In Tech, Inc. amends its Form S-3 shelf registration to offer up to $300,000,000 of securities, subject to a Baby Shelf Limitation. The shelf permits sales of common stock, preferred stock, warrants, debt, subscription rights and units in one or more offerings; specific terms will be set forth in prospectus supplements.
The prospectus states the company had a public float of approximately $32.3 million based on 53,858,083 shares of Class A Common Stock outstanding and a referenced price of $1.57 per share as of May 7, 2026. The filing notes an aggregate offering cap of $300,000,000 and discloses plan to use proceeds for general corporate purposes.
Health In Tech, Inc. filed a shelf registration on Form S-3 to register up to $300,000,000 of securities to be offered from time to time after this Registration Statement becomes effective. The shelf covers Common Stock, Preferred Stock, Warrants, Debt Securities, Subscription Rights and Units.
The prospectus states proceeds will be used for general corporate purposes, including working capital, capital expenditures, research and development and acquisitions. As of June 10, 2026, the company reports 53,842,109 shares of Class A Common Stock and 11,700,000 shares of Class B Common Stock issued and outstanding; 1,900,825 options are outstanding.
Health In Tech, Inc. is registering up to 5,600,000 shares of Class A Common Stock for resale by the selling stockholders.
This prospectus forms part of a shelf registration that permits the named selling stockholders to resell their Class A Common Stock from time to time; the company will not receive any proceeds from those resales. The Registration Rights Agreement arose from a PIPE Offering that closed on March 27, 2026.
Health In Tech, Inc. is registering 5,600,000 shares of Class A Common Stock for resale by selling stockholders under a shelf registration. The resale shares were issued in a PIPE and the company will receive no proceeds from secondary sales.
The registration covers shares issued in the PIPE Offering that closed on March 27, 2026 and is being filed pursuant to the related Registration Rights Agreement. The prospectus lists plan of distribution options and states shares may be sold on Nasdaq (symbol HIT) or by other permitted methods.